---
layout: single
title:  "FDA approves first T-cell therapy for a solid tumor"
categories: oncology

---
Using a tumor derived immunotherapy composed of a patient's own disease-fighting white blood cells known as T-cells - specific type called tumor-infiltrating lymphocytes (TIL).

[Fierce Pharma](https://www.fiercepharma.com/pharma/fda-approves-iovances-amtagvi-first-cell-therapy-solid-tumor)
